Neonatal myasthenia gravis is uncommon and life threatening. We describe the use of intravenously administered immunoglobulin, in addition to conventional modalities, in a neonate with severe neonatal myasthenia gravis. However, despite this aggressive management, the child had a prolonged period of weakness requiring intensive care.
|Number of pages||3|
|Journal||Journal of Pediatrics|
|State||Published - 1999|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health